RE:$RVV $RVVTF - Corporate Fact Sheet Q1-2021 !Upcoming Milestones Q1
Phase 3 study update @ 210 patients--> NO data offered, lip service
Submit IND for phase 2 study for CBD--> NO
Psilo oral thin film scale-up--> maybe yes
Psilo reseach results TBI--> NO
Begin Phase 1, Psilo in Meth Dis--> NO
Q2 ends in 45 days. Covid 19 in developed countries will also.
The new India variant is making it's way through the UK, population 70 million (twice Canada), 54% of the population has been vacinated.
Deaths yesterday--> 7
If you get vaccinated you may still get Covid, but you won't die. The Covid vaccine will be updated yearly and be offered just like the flu shot.
It's over, get your vaccine and get on with your life.
For those of you here waiting for Bucillamine to make you rich, find an exit. Even if Buc recieves FDA approval Pfizer or some other big Pharma is working to develop and will eventually show better results.
Any prize will be short lived. The SP WILL NOT get to $4 on Bucillamine.
Cool, wake up. Think. This is a mushroom play, the sooner RVV end the burn (currently pegged at 20 million this year) on Bucillamine and focus on Psilo, the better for investors. That is your 20 million RVV is burning, you realize that?